Skip to content

Medical emergency? What to do

Pregnancy may help protect against bladder cancer

3-RXPublished June 26, 20084 min read

Key points

  • Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found.
  • The researchers led by Jay Reeder, Ph.D., are focusing on a fact that has puzzled doctors and scientists for decades: Why does bladder cancer, the fifth most common malignancy in the nation, affect about three times as many men as women?
  • First author Aimee Johnson was investigating ways in which hormones might make males more vulnerable to bladder cancer.
  • "We were shocked at the differences between the two groups," said Reeder.

Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found.

Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings by investigators at the University of Rochester Medical Center. Their work appears online as a rapid communication in the journal Urology.

The researchers led by Jay Reeder, Ph.D., are focusing on a fact that has puzzled doctors and scientists for decades: Why does bladder cancer, the fifth most common malignancy in the nation, affect about three times as many men as women? Scientists long blamed men's historically higher rates of smoking and greater exposure to dangers in the workplace, but the gap has persisted even as women swelled the workforce and took up smoking in greater numbers.

"While some researchers have asked why men are more vulnerable to bladder cancer, perhaps we should be asking why women have more protection," said Reeder, a research assistant professor in the departments of Pathology and Laboratory Medicine, Urology, and Imaging Sciences. "When it comes to bladder cancer, being female is a very good thing."

First author Aimee Johnson was investigating ways in which hormones might make males more vulnerable to bladder cancer. She was comparing rates of bladder cancer in male and female mice when she took a closer look at the females. She found an unexpected, marked difference in cancer rates and volumes among the female mice.

Female mice that had gotten pregnant repeatedly had far fewer bladder cancers than both their normal male counterparts and their female counterparts that had never gotten pregnant. On average, the total tumor volume was about 15 times greater in female mice that had never gotten pregnant compared to mice that had gotten pregnant.

"We were shocked at the differences between the two groups," said Reeder. "These mice were specially susceptible to bladder cancer, yet we saw virtually no cancer in the females that had become pregnant.

"The mice that were pregnant nursed their offspring, and a protective effect could be related to pregnancy, lactation, or both. Additional studies are needed to identify the specific mechanism."

While scientists do know that early onset of menopause increases a woman's risk of getting bladder cancer, pregnancy hasn't generally been considered a possible factor in determining one's risk for bladder cancer, said Reeder.

Reeder's team used a sophisticated imaging instrument known as a cone-beam CT scanner to take some of the most detailed images ever of a developing cancer in mice with the disease. Cancers of the bladder grow into the hollow space from the lining of the bladder, somewhat resembling tiny heads of sprouting broccoli.

The imaging was done thanks to a collaboration with scientists at Koning Inc., a Rochester-based start-up company based on technology developed by Ruola Ning, Ph.D. Koning scientist David Conover worked closely with Reeder's team to customize the technology to evaluate bladder cancer as it develops.

The results highlight a possible role for hormones in bladder cancer, perhaps like the known role hormones have in the development of breast cancer. Most hormone research in bladder cancer has focused on male hormones such as testosterone and their capability of boosting the cancer process.

In April, Reeder's team published an article in BMC Urology showing one way male hormones might boost bladder cancer risk. The team demonstrated a link between testosterone and the ability of new tissue to form new blood vessels, a crucial ability for cancerous tissue as it seeks to grow.

Scientists showed that male mice with a normal amount of testosterone have less of a protein known as thrombospondin-1 (TSP1), which helps to stop new blood vessels from forming. When Reeder's team cut off the supply of testosterone, TSP1 levels were boosted in male mice, and they had fewer bladder tumors, perhaps because their blood supply had been cut off.

The team made a similar finding in people with bladder cancer. In an analysis of human bladder tissue done together with colleagues at the University's James P. Wilmot Cancer Center, cancerous tissue had lower levels of TSP1 than normal tissue.

###

Johnson did the work as a graduate student in Reeder's laboratory and is now a researcher at the University of Oklahoma. In addition to Johnson and Reeder, other authors of the papers include technical associate Mary J. O'Connell; pathologist Hiroshi Miyamoto, M.D., Ph.D.; Jiaoti Huang, M.D.; Jorge Yao, M.D.; and Edward Messing, M.D.

The work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Department of Urology.

Contact: Tom Rickey
tom_rickey@urmc.rochester.edu
585-275-7954
University of Rochester Medical Center

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.